Search research articles
Contact Us
Filters
Showing results (111-120 of 212) with videos related to
Page
of 22
Sort By:
Molecular Imaging
|
September 5, 2009
Metabolism of orthotopic mouse brain tumor models
Michael Rosol, Ira Harutyunyan, Jingying Xu, et al.
Pediatric Blood & Cancer
|
February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
Malcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer
|
March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program
Malcolm A Smith, John M Maris, Richard Lock, et al.
BMC Research Notes
|
April 24, 2014
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study
Min H Kang, Judith G Villablanca, Julia L Glade Bender, et al.
Pediatric Blood & Cancer
|
February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
E Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer
|
June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing program
Mimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer
|
August 19, 2014
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program
Peter J Houghton, Raushan T Kurmasheva, Dmitry Lyalin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study
Katherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Genes, Chromosomes & Cancer
|
December 22, 2022
Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression
Kevin Stachelek, Narine Harutyunyan, Susan Lee, et al.
Pediatric Blood & Cancer
|
October 5, 2007
Initial testing of dasatinib by the pediatric preclinical testing program
E Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 212) with videos related to
Sort By:
Page
of 22
Molecular Imaging
|
September 5, 2009
Metabolism of orthotopic mouse brain tumor models
Michael Rosol, Ira Harutyunyan, Jingying Xu, et al.
Pediatric Blood & Cancer
|
February 9, 2008
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
Malcolm A Smith, Christopher L Morton, Doris A Phelps, et al.
Pediatric Blood & Cancer
|
March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program
Malcolm A Smith, John M Maris, Richard Lock, et al.
BMC Research Notes
|
April 24, 2014
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study
Min H Kang, Judith G Villablanca, Julia L Glade Bender, et al.
Pediatric Blood & Cancer
|
February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
E Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer
|
June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing program
Mimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer
|
August 19, 2014
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program
Peter J Houghton, Raushan T Kurmasheva, Dmitry Lyalin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study
Katherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Genes, Chromosomes & Cancer
|
December 22, 2022
Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression
Kevin Stachelek, Narine Harutyunyan, Susan Lee, et al.
Pediatric Blood & Cancer
|
October 5, 2007
Initial testing of dasatinib by the pediatric preclinical testing program
E Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Page
of 22